The mission of the Genome Engineering Shared Resource (GESR) is to provide state-of-the-art services in precision genome engineering of mammalian cell lines to Masonic Cancer Center (MCC) researchers. Specifically, the GESR is capable of genetically engineering human cell lines tailored to each principal investigator's (PI's) individual specifications. These services include, but are not limited to 1) single guide RNA (sgRNA) design; 2) sgRNA validation; 3) sgRNA expression vector construction; 4) design of CRISPR (Clustered Regularly Interspersed Palindromic Repeats)-associated 9 (Cas9) protein expression vector reagents; 5) simple, single-locus knockouts for non-essential genes; 6) construction of conditionally null alleles for essential genes; 7) construction of single-amino-acid knock-in mutations; 8) construction of single- nucleotide knock-ins; 9) construction of multi-allelic knockout cell lines; and 10) in collaboration with the Mouse Genetics Laboratory (MGL) Shared Resource, construction of RNA- and protein-based CRISPR/Cas9 reagents for the generation of transgenic mice. These services are essential to the mission of the MCC because genetic alteration of human cancer cell lines allows PIs the ability to design mechanistic and therapeutic experiments related to the characterization and investigation of specific cancers. Moreover, although the demand for genetically modified human cell lines is high, the steps involved in the process of genome editing are still technically challenging and time consuming and demand resources and a level of expertise not found in most clinical laboratories. The GESR is capable of providing these services at a very cost-effective price (well below most commercial sources) and can usually generate the requisite reagent or cell line as quickly (or more quickly) than most commercial enterprises. The GESR is co-led by Drs. Eric A. Hendrickson and Branden S. Moriarity and coordinated by Brian Ruis with support from 2 laboratory personnel. The GESR has been in operation since October 2015.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Ma, Bin; Zarth, Adam T; Carlson, Erik S et al. (2018) Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 31:48-57
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891
Lee, Hak Rae; Leslie, Faith; Azarin, Samira M (2018) A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2. J Biol Eng 12:12
Yang, Libang; Herrera, Jeremy; Gilbertsen, Adam et al. (2018) IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. Am J Physiol Lung Cell Mol Physiol 314:L127-L136
Regan Anderson, Tarah M; Ma, Shihong; Perez Kerkvliet, Carlos et al. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res 16:1761-1772
Grzywacz, Bartosz; Moench, Laura; McKenna Jr, David et al. (2018) Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control. J Immunother :
Santiago, Victor; Lazaryan, Aleksandr; McClune, Brian et al. (2018) Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome. Leuk Lymphoma 59:958-966
Guo, Jingshu; Villalta, Peter W; Weight, Christopher J et al. (2018) Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry. Chem Res Toxicol :
Boatman, Jeffrey A; Vock, David M; Koopmeiners, Joseph S et al. (2018) Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics 19:103-118
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. Br J Haematol 182:887-894

Showing the most recent 10 out of 1013 publications